Gallium-mediated siderophore quenching as an evolutionarily robust antibacterial treatment
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: Conventional antibiotics select strongly for resistance and are consequently losing efficacy worldwide. Extracellular quenching of shared virulence factors could represent a more promising strategy because (i) it reduces the available routes to resistance (as extracellular action precludes any mutations blocking a drug's entry into cells or hastening its exit) and (ii) it weakens selection for resistance, as fitness benefits to emergent mutants are diluted across all cells in a cooperative collective. Here, we tested this hypothesis empirically. METHODOLOGY: We used gallium to quench the iron-scavenging siderophores secreted and shared among pathogenic Pseudomonas aeruginosa bacteria, and quantitatively monitored its effects on growth in vitro. We assayed virulence in acute infections of caterpillar hosts (Galleria mellonella), and tracked resistance emergence over time using experimental evolution. RESULTS: Gallium strongly inhibited bacterial growth in vitro, primarily via its siderophore quenching activity. Moreover, bacterial siderophore production peaked at intermediate gallium concentrations, indicating additional metabolic costs in this range. In vivo, gallium attenuated virulence and growth-even more so than in infections with siderophore-deficient strains. Crucially, while resistance soon evolved against conventional antibiotic treatments, gallium treatments retained their efficacy over time. CONCLUSIONS: Extracellular quenching of bacterial public goods could offer an effective and evolutionarily robust control strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, gallium (Ga2+) quenching of P. aeruginosa siderophores reduced pathogenesis in a Galleria mellonella model and retained efficacy longer than the conventional antibiotics gentamicin and ciprofloxacin (118).”
From Transition Metals and Virulence in Bacteria (2016) · cites this paper as [118]
Experimental — accuracy not yet measuredIn the citing paper
“For example, gallium (Ga2+) quenching of P. aeruginosa siderophores reduced pathogenesis in a Galleria mellonella model and retained efficacy longer than the conventional antibiotics gentamicin and ciprofloxacin (118).”
From Transition Metals and Virulence in Bacteria (2016) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Antibiotics for Emerging Pathogens
Fischbach, M. A., & Walsh, C. T. (2009) · Science · doi:10.1126/science.1176667 · Cited by 1,777 · cited 1×
“Consequently, the therapy will lose efficacy [1, 2].”
Siderophore-Based Iron Acquisition and Pathogen Control
Miethke, M., & Marahiel, M. A. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00012-07 · Cited by 1,774 · cited 1×
“Siderophores are diffusible molecules with a high affinity for ferric iron (Fe3þ) and are secreted by most bacteria to scavenge this important but generally bio-unavailable form of iron from their environment or, in the case of pathogens, from their host’s own iron-chelating compounds [17].”
BackgroundAnti-virulence strategies to combat bacteria-mediated disease
Rasko, D. A., & Sperandio, V. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3013 · Cited by 1,373 · cited 2×
“‘Antivirulence’ treatments, meanwhile, ostensibly disarm but do not harm pathogens, such that resistant variants should benefit little relative to susceptibles [4].”
BackgroundCooperation and competition in pathogenic bacteria
Griffin, A. S., West, S. A., & Buckling, A. (2004) · Nature · doi:10.1038/nature02744 · Cited by 1,104 · cited 1×
“Low (a) Pyoverdine molecules are shared across the local community [47], so producers of the novel and the ancestral pyoverdine types would benefit similarly.”
Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
Fernández, L., & Hancock, R. E. W. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-12 · Cited by 892 · cited 1×
“modified membrane properties to block a drug’s entry into a cell, or upregulated efflux pumps to hasten its exit [15]).”
BackgroundExploiting Quorum Sensing To Confuse Bacterial Pathogens
LaSarre, B., & Federle, M. J. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00046-12 · Cited by 820 · cited 1×
“Quorum quenching (QQ), which disrupts the cell-to-cell communication [quorum sensing (QS)] [9] underlying a wide range of collectively expressed virulence traits, is a PG-targeting ‘antivirulence’ therapy regarded as a promising alternative to conventional bacteriocidal or bacteriostatic treatments [10, 11].”
BackgroundIron and Pseudomonas aeruginosa biofilm formation
Banin, E., Vasil, M. L., & Greenberg, E. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504266102 · Cited by 801 · cited 1×
“Cornelis, Free University of Brussels, Belgium, as well as versions of the above strains constitutively expressing GFP (PAO1-gfp, PAO1 pvdD-gfp, chromosomal insertion: attTn7::ptac-gfp), and a version of PAO1 with a pvdA-gfp reporter fusion (PAO1pvdA-gfp, chromosomal insertion: attB::pvdA-gfp) [27], provided by P.”
Where will new antibiotics come from?
Walsh, C. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro727 · Cited by 755 · cited 1×
“In light of our results, we contend that this approach—and more generally the extracellular targeting of PGs—could curb microbial virulence in an evolutionarily robust manner, and therefore represents a promising alternative to our dwindling succession of traditional antibiotics [59–61].”
BackgroundThe Multiple Signaling Systems Regulating Virulence in Pseudomonas aeruginosa
Nadal Jimenez, P., Koch, G., Thompson, J. A., Xavier, K. B., Cool, R. H., & Quax, W. J. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05007-11 · Cited by 736 · cited 1×
“Anticipating that the experimental evolution described above might have induced changes in these traits, we performed phenotypic assays to compare cultures of our ancestral PAO1 WT, its descendent lines experimentally evolved in CAA with or without supplementation with 20 mM Ga, and also two knock-out mutant strains w…”
MethodWest, S. A., Diggle, S. P., Buckling, A., Gardner, A., & Griffin, A. S. (2007) · Annual Review of Ecology, Evolution, and Systematics · doi:10.1146/annurev.ecolsys.38.091206.095740 · Cited by 696 · cited 2×
“In co-infection with siderophore producers, non-producing mutants could act as cheats—no longer investing in the PG yet still benefiting from the investment of nearby ancestors [5].”
BackgroundKaneko, Y., Thoendel, M., Olakanmi, O., Britigan, B. E., & Singh, P. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30783 · Cited by 661 · cited 7×
“aeruginosa growth and biofilm formation by quenching local stocks of secreted pyoverdine and choking off iron supply [19, 25].”
BackgroundInfluentialSiderophore-mediated signaling regulates virulence factor production in Pseudomonas aeruginosa
Lamont, I. L., Beare, P. A., Ochsner, U., Vasil, A. I., & Vasil, M. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092016999 · Cited by 584 · cited 1×
“Positive feedback occurs when incoming Fe-bound siderophores act via the receptor FpvA and the anti-sigma factor FpvR to activate membrane-bound iron-starvation sigma factor PvdS [37].”
BackgroundAcyl-Homoserine Lactone Quorum Sensing: From Evolution to Application
Schuster, M., Joseph Sexton, D., Diggle, S. P., & Peter Greenberg, E. (2013) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092412-155635 · Cited by 556 · cited 1×
“Quorum quenching (QQ), which disrupts the cell-to-cell communication [quorum sensing (QS)] [9] underlying a wide range of collectively expressed virulence traits, is a PG-targeting ‘antivirulence’ therapy regarded as a promising alternative to conventional bacteriocidal or bacteriostatic treatments [10, 11].”
BackgroundTargeting virulence: can we make evolution-proof drugs?
Allen, R. C., Popat, R., Diggle, S. P., & Brown, S. P. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3232 · Cited by 532
Self-citationPyoverdin is essential for virulence of Pseudomonas aeruginosa
Meyer, J. M., Neely, A., Stintzi, A., Georges, C., & Holder, I. A. (1996) · Infection and Immunity · doi:10.1128/iai.64.2.518-523.1996 · Cited by 521
grofit: Fitting Biological Growth Curves with R
Kahm, M., Hasenbrink, G., Lichtenberg-Fraté, H., Ludwig, J., & Kschischo, M. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i07 · Cited by 514 · cited 1×
“Spline curves were fitted to time course growth data using the ‘grofit’ package [34].”
MethodMechanisms of Therapeutic Activity for Gallium
Bernstein, L. R. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01383-8 · Cited by 446 · cited 1×
“At lower concentrations, efficacy should initially increase with dose, but at too high concentrations, gallium may increasingly transit across the cell membrane and begin to interfere directly with iron metabolism, causing general toxicity to bacteria and host cells alike (Fig 1A; [36]).”
BackgroundRead, A. F. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90537-1 · Cited by 428 · cited 1×
“However, pathogen fitness and virulence will not always be strongly positively correlated [43, 52].”
BackgroundBacterial Quorum Sensing and Metabolic Incentives to Cooperate
Dandekar, A. A., Chugani, S., & Greenberg, E. P. (2012) · Science · doi:10.1126/science.1227289 · Cited by 332 · cited 1×
“Second, QS regulates not only PGs but also certain essential private goods [16], giving QQ resistants substantial personal benefits over susceptibles—and therefore a means to spread.”
BackgroundQuenching the quorum sensing system: potential antibacterial drug targets
Kalia, V. C., & Purohit, H. J. (2011) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2010.532479 · Cited by 310 · cited 1×
“Quorum quenching (QQ), which disrupts the cell-to-cell communication [quorum sensing (QS)] [9] underlying a wide range of collectively expressed virulence traits, is a PG-targeting ‘antivirulence’ therapy regarded as a promising alternative to conventional bacteriocidal or bacteriostatic treatments [10, 11].”
BackgroundQuorum quenching quandary: resistance to antivirulence compounds
Maeda, T., García-Contreras, R., Pu, M., Sheng, L., Garcia, L. R., Tomás, M., & Wood, T. K. (2012) · The ISME Journal · doi:10.1038/ismej.2011.122 · Cited by 300 · cited 1×
“However, early enthusiasm for QQ has been tempered recently by reports that bacteria can quite readily evolve resistance to such treatments [12–14].”
BackgroundEvers, A., Hancock, R. D., Martell, A. E., & Motekaitis, R. J. (1989) · Inorganic Chemistry · doi:10.1021/ic00310a035 · Cited by 290
Discovery research: the scientific challenge of finding new antibiotics
Livermore, D. M., on behalf of the British Society for Antimicrobial Chemotherapy Working Party on The Urgent Need: Regenerating Antibacterial Drug Discovery and Development, Blaser, M., Carrs, O., Cassell, G., Fishman, N., Guidos, R., Levy, S., Powers, J., Norrby, R., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr262 · Cited by 284 · cited 1×
“In light of our results, we contend that this approach—and more generally the extracellular targeting of PGs—could curb microbial virulence in an evolutionarily robust manner, and therefore represents a promising alternative to our dwindling succession of traditional antibiotics [59–61].”
BackgroundImpact of Siderophore Production on Pseudomonas aeruginosa Infections in Immunosuppressed Mice
Takase, H., Nitanai, H., Hoshino, K., & Otani, T. (2000) · Infection and Immunity · doi:10.1128/iai.68.4.1834-1839.2000 · Cited by 269 · cited 1×
“Pyoverdine, which plays an important role in such infections [23, 24], binds gallium at least as readily as iron, and gallium-bound pyoverdine is of no use to iron-starved cells [19, 20].”
BackgroundThe potential of desferrioxamine-gallium as an anti- Pseudomonas therapeutic agent
Banin, E., Lozinski, A., Brady, K. M., Berenshtein, E., Butterfield, P. W., Moshe, M., Chevion, M., Greenberg, E. P., & Banin, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808608105 · Cited by 258 · cited 2×
“as an anti-cancer drug [56]) and has previously been proposed, and tested, as a treatment against bacterial infections [19, 25, 57, 58].”
BackgroundNew insights into the metal specificity of the Pseudomonas aeruginosa pyoverdine–iron uptake pathway
Braud, A., Hoegy, F., Jezequel, K., Lebeau, T., & Schalk, I. J. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2008.01838.x · Cited by 246 · cited 3×
“Low (a) Pyoverdine has already evolved high iron specificity [20].”
BackgroundCan Bacteria Evolve Resistance to Quorum Sensing Disruption?
Defoirdt, T., Boon, N., & Bossier, P. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000989 · Cited by 229 · cited 1×
“However, early enthusiasm for QQ has been tempered recently by reports that bacteria can quite readily evolve resistance to such treatments [12–14].”
BackgroundThe Pseudomonas aeruginosa Pyochelin-Iron Uptake Pathway and Its Metal Specificity
Braud, A., Hannauer, M., Mislin, G. L. A., & Schalk, I. J. (2009) · Journal of Bacteriology · doi:10.1128/jb.00010-09 · Cited by 222 · cited 1×
“(b) Gallium can quench pyochelin too, and so it still inhibits iron uptake [49].”
BackgroundMolecular basis of pyoverdine siderophore recycling in Pseudomonas aeruginosa
Imperi, F., Tiburzi, F., & Visca, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908760106 · Cited by 218 · cited 1×
“Once loaded with Fe3þ, siderophores are taken up by producer cells—or other nearby individuals equipped with appropriate receptors— stripped of their iron, and secreted once again into the environment [18].”
BackgroundIron acquisition and its control in Pseudomonas aeruginosa: Many roads lead to Rome
Poole, K. (2003) · Frontiers in Bioscience · doi:10.2741/1051 · Cited by 217
Pyoverdine biosynthesis and secretion in Pseudomonas aeruginosa : implications for metal homeostasis
Schalk, I. J., & Guillon, L. (2013) · Environmental Microbiology · doi:10.1111/1462-2920.12013 · Cited by 213 · cited 1×
“We investigated the iron-mimicking effects of gallium on pyoverdine, the primary siderophore of Pseudomonas aeruginosa [21], a widespread opportunistic pathogen with a broad host range and, in humans, the cause of Quenching public goods as a robust antibacterial treatment Ross-Gillespie et al.”
BackgroundViscous medium promotes cooperation in the pathogenic bacterium Pseudomonas aeruginosa
Kümmerli, R., Griffin, A. S., West, S. A., Buckling, A., & Harrison, F. (2009) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2009.0861 · Cited by 209 · cited 1×
“In mixed cultures, gallium reduces total population density and the effective group size at which pyoverdine can be shared, and these effects both disfavor the mutant [45, 46].”
BackgroundSelf-citationWilderman, P. J., Vasil, A. I., Johnson, Z., Wilson, M. J., Cunliffe, H. E., Lamont, I. L., & Vasil, M. L. (2001) · Infection and Immunity · doi:10.1128/iai.69.9.5385-5394.2001 · Cited by 204 · cited 1×
“1B), and in some contexts, this could potentially lead to higher virulence, given that pyoverdine production is linked to certain other virulence factors [53, 54].”
BackgroundGallium-Containing Anticancer Compounds
Chitambar, C. R. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.69 · Cited by 198 · cited 1×
“as an anti-cancer drug [56]) and has previously been proposed, and tested, as a treatment against bacterial infections [19, 25, 57, 58].”
BackgroundCooperation and virulence in acute Pseudomonas aeruginosainfections
Harrison, F., Browning, L. E., Vos, M., & Buckling, A. (2006) · BMC Biology · doi:10.1186/1741-7007-4-21 · Cited by 196 · cited 1×
“In any event, the rise of such mutants should still lead to less virulent infections (Fig 2A-C; [42-44]).”
Dumas, Z., Ross-Gillespie, A., & Kümmerli, R. (2013) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2013.1055 · Cited by 195 · cited 1×
“Regulatory mechanisms already exist to facilitate facultative switching between siderophore types in response to changing iron stress [48].”
BackgroundSelf-citationFpvB, an alternative type I ferripyoverdine receptor of Pseudomonas aeruginosa
Ghysels, B., Dieu, B. T. M., Beatson, S. A., Pirnay, J.-P., Ochsner, U. A., Vasil, M. L., & Cornelis, P. (2004) · Microbiology · doi:10.1099/mic.0.27035-0 · Cited by 190 · cited 1×
“Pseudomonas aeruginosa strains featured in our experiments included the wild-type strain PAO1 (ATCC 15692), the siderophore knock-out mutants PAO1 pvdD and PAO1 pvdD pchEF [26], provided by P.”
MethodGallium-based anti-infectives: targeting microbial iron-uptake mechanisms
Kelson, A. B., Carnevali, M., & Truong-Le, V. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.07.001 · Cited by 175 · cited 1×
“as an anti-cancer drug [56]) and has previously been proposed, and tested, as a treatment against bacterial infections [19, 25, 57, 58].”
BackgroundPhenotypic plasticity of a cooperative behaviour in bacteria
KÜMMERLI, R., JIRICNY, N., CLARKE, L. S., WEST, S. A., & GRIFFIN, A. S. (2009) · Journal of Evolutionary Biology · doi:10.1111/j.1420-9101.2008.01666.x · Cited by 174 · cited 2×
“On the other hand, it has also been shown that pyoverdine production is upregulated in response to more stringent iron limitation [28], as presumably induced by gallium.”
BackgroundMethodSelf-citationQuorum Sensing Inhibition Selects for Virulence and Cooperation in Pseudomonas aeruginosa
Köhler, T., Perron, G. G., Buckling, A., & van Delden, C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000883 · Cited by 171 · cited 1×
“In any event, the rise of such mutants should still lead to less virulent infections (Fig 2A-C; [42-44]).”
BackgroundA call for antibiotic alternatives research
Stanton, T. B. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2012.11.002 · Cited by 168 · cited 1×
“In light of our results, we contend that this approach—and more generally the extracellular targeting of PGs—could curb microbial virulence in an evolutionarily robust manner, and therefore represents a promising alternative to our dwindling succession of traditional antibiotics [59–61].”
BackgroundThe Sociomicrobiology of Antivirulence Drug Resistance: a Proof of Concept
Mellbye, B., & Schuster, M. (2011) · mBio · doi:10.1128/mbio.00131-11 · Cited by 164
DENSITY DEPENDENCE AND COOPERATION: THEORY AND A TEST WITH BACTERIA
Ross-Gillespie, A., Gardner, A., Buckling, A., West, S. A., & Griffin, A. S. (2009) · Evolution · doi:10.1111/j.1558-5646.2009.00723.x · Cited by 134 · cited 1×
“In mixed cultures, gallium reduces total population density and the effective group size at which pyoverdine can be shared, and these effects both disfavor the mutant [45, 46].”
BackgroundSelf-citationFunctional Analysis of PvdS, an Iron Starvation Sigma Factor of Pseudomonas aeruginosa
Leoni, L., Orsi, N., de Lorenzo, V., & Visca, P. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.6.1481-1491.2000 · Cited by 132 · cited 1×
“In this case, the Fe2þ induces Fur (ferric uptake regulator)-mediated repression of pvdS [38].”
BackgroundResistance to Quorum-Quenching Compounds
García-Contreras, R., Maeda, T., & Wood, T. K. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.02378-13 · Cited by 131
Ochsner, U. A., Johnson, Z., Lamont, I. L., Cunliffe, H. E., & Vasil, M. L. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.481425.x · Cited by 126 · cited 1×
“1B), and in some contexts, this could potentially lead to higher virulence, given that pyoverdine production is linked to certain other virulence factors [53, 54].”
BackgroundGallium Maltolate Treatment Eradicates Pseudomonas aeruginosa Infection in Thermally Injured Mice
DeLeon, K., Balldin, F., Watters, C., Hamood, A., Griswold, J., Sreedharan, S., & Rumbaugh, K. P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01330-08 · Cited by 123 · cited 1×
“as an anti-cancer drug [56]) and has previously been proposed, and tested, as a treatment against bacterial infections [19, 25, 57, 58].”
BackgroundReszka, K. J., O’Malley, Y., McCormick, M. L., Denning, G. M., & Britigan, B. E. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.03.011 · Cited by 120 · cited 1×
“After 24 h, we measured OD 600, centrifuged at 7000 rpm for 2min, then extracted 200ml aliquots of supernatant and assayed these for growth (OD at 600 nm) and levels of pyocyanin (usingODat 691 nm) [32] and pyoverdine (fluorescence at 400j460 nm), using a Tecan Infinite M-200 plate reader.”
MethodFitness correlates with the extent of cheating in a bacterium
JIRICNY, N., DIGGLE, S. P., WEST, S. A., EVANS, B. A., BALLANTYNE, G., ROSS‐GILLESPIE, A., & GRIFFIN, A. S. (2010) · Journal of Evolutionary Biology · doi:10.1111/j.1420-9101.2010.01939.x · Cited by 112 · cited 1×
“High Low Pyoverdine-negative mutants arise readily [39, 41].”
Self-citationCost of cooperation rules selection for cheats in bacterial metapopulations
DUMAS, Z., & KÜMMERLI, R. (2012) · Journal of Evolutionary Biology · doi:10.1111/j.1420-9101.2011.02437.x · Cited by 92 · cited 1×
“High Low Pyoverdine-negative mutants arise readily [39, 41].”
Self-citationMulticellular organization in bacteria as a target for drug therapy
André, J., & Godelle, B. (2005) · Ecology Letters · doi:10.1111/j.1461-0248.2005.00783.x · Cited by 78
Severe Infections Caused by Pseudomonas Aeruginosa
Hauser, A. R., & Rello, J. (2003) · Perspectives on critical care infectious diseases · doi:10.1007/978-1-4615-0433-7 · Cited by 68 · cited 1×
“notoriously persistent infections in immunecompromised tissues, cystic fibrosis lungs and in association with implanted devices [22].”
BackgroundIsolation and characterization of gallium resistant Pseudomonas aeruginosa mutants
García‐Contreras, R., Lira‐Silva, E., Jasso‐Chávez, R., Hernández-González, I., Maeda, T., Hashimoto, T., Boogerd, F. C., Sheng, L., Wood, T. K., & Moreno‐Sánchez, R. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.07.009 · Cited by 63 · cited 3×
“Indeed, overproducers of pyocyanin, a redoxactive metabolite, have recently been reported to be refractory to gallium [30], and in our own experiments, we did see a weak but significant mean increase in pyocyanin production under certain conditions among cultures evolved under gallium treatment (Fig.”
BackgroundResultInfluentialGallium induces the production of virulence factors inPseudomonas aeruginosa
García‐Contreras, R., Peréz-Eretza, B., Lira‐Silva, E., Jasso‐Chávez, R., Coria‐Jiménez, R., Rangel-Vega, A., Maeda, T., & Wood, T. K. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12105 · Cited by 61 · cited 1×
“Indeed, while gallium is generally known to reduce virulence [19], one recent study [55] showed that in very dense cultures, gallium supplementation actually upregulated production of certain virulence factors.”
BackgroundRead, A. F., & Harvey, P. (1993) · Nature · doi:10.1038/362500a0 · Cited by 54
Drugs that target pathogen public goods are robust against evolved drug resistance
Pepper, J. W. (2012) · Evolutionary Applications · doi:10.1111/j.1752-4571.2012.00254.x · Cited by 51 · cited 1×
“Under PG-quenching therapy, any mutations allowing PGs to build up again should benefit both resistant and susceptible individuals alike, which would hinder the spread of resistance [1, 6–8].”
BackgroundDEFEATING PATHOGEN DRUG RESISTANCE: GUIDANCE FROM EVOLUTIONARY THEORY
Pepper, J. W. (2008) · Evolution · doi:10.1111/j.1558-5646.2008.00525.x · Cited by 41
Racey, D. N., Inglis, R. F., Harrison, F., Oliver, A., & Buckling, A. (2009) · Evolution · doi:10.1111/j.1558-5646.2009.00821.x · Cited by 41
Evers, A., Hancock, R. D., Martell, A. E., & Motekaitis, R. J. (1989) · ChemInform · doi:10.1002/chin.198938082 · Cited by 19 · cited 1×
“desferrioxamine) are still prone to bind gallium [51].”
Background[Treatment of Pseudomonas aeruginosa infections].
Bergan, T. (1969) · PubMed · Cited by 5
Ross‐Gillespie, A. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 3
Self-citation
Cited by
Langdon, A., Crook, N., & Dantas, G. (2016) · Genome Medicine · doi:10.1186/s13073-016-0294-z · Cited by 912
“Compounds that inactivate siderophores therefore represent an evolutionarily robust antivirulence strategy [133].”
BackgroundMultidrug evolutionary strategies to reverse antibiotic resistance
Baym, M., Stone, L. K., & Kishony, R. (2016) · Science · doi:10.1126/science.aad3292 · Cited by 710
Targeting virulence: can we make evolution-proof drugs?
Allen, R. C., Popat, R., Diggle, S. P., & Brown, S. P. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3232 · Cited by 532
Self-citationTransition Metals and Virulence in Bacteria
Palmer, L. D., & Skaar, E. P. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-120215-035146 · Cited by 449
Applications of Metals for Bone Regeneration
Glenske, K., Donkiewicz, P., Köwitsch, A., Milosevic-Oljaca, N., Rider, P., Rofall, S., Franke, J., Jung, O., Smeets, R., Schnettler, R., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030826 · Cited by 247
“In this manner, gallium downregulates bacterial iron uptake and impairs bacterial growth [140].”
Background
Metadata
- Authors
- Ross-Gillespie, A., Weigert, M., Brown, S. P., & Kümmerli, R.
- Affiliations
- University of Zurich (CH)
- Venue
- Evolution, Medicine, and Public Health
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-01
- Volume
- 2014
- Issue
- 1
- Pages
- 18-29
- ISSN
- 2050-6201 (ISSN-L)
- PMC
- PMC3935367
- OpenAlex
- W2157642827
- Cited by
- 104
- References
- 63
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 4 · 2021: 8 · 2020: 12 · 2019: 9 · 2018: 7 · 2017: 13 · 2016: 18 · 2015: 12 · 2014: 6
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Evolution Medicine and Public Health (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- DORA Eawag (Swiss Federal Institute of Aquatic Science and Technology (Eawag)) (submittedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- gallium, Pseudomonas aeruginosa, antibiotic resistance, virulence attenuation, Galleria mellonella, experimental evolution, public goods, iron acquisition, antibiotic therapy, bacterial virulence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.